• Covid-19. The first immunized to the coronavirus in Spain with the two doses of the vaccine: "I'm fine, fine fine"

  • Vaccines: Pfizer to reduce vaccine deliveries to Europe

The Spanish pharmaceutical group

Insud Pharma will

manufacture, at its

Azuqueca de Henares

(

Guadalajara

) plant, vials of the

AZD1222

vaccine

developed by

AstraZeneca

and the

University of Oxford

, and will be in charge of filling and packaging them.

The Government of

Castilla-La Mancha

has reported in a statement that production will begin at the plant in its industrial area,

Chemo

, located in Azuqueca de Henares (Guadalajara), next February.

The Castilian

-

Manchego

president,

Emiliano García-Page

, who has accompanied the Minister of Health,

Salvador Illa

, in his visit to the company's facilities in the Azudense town, has said that this plant is going to be "the protagonist in one of the most popular vaccines important "against

Covid-19

.

"For us it is a source of pride and a guarantee that the vaccine will leave here", García-Page pointed out, and has affected their satisfaction because, in addition to the benefits that the vaccine will bring to public health, it will also entail the creation of more jobs.

"A milestone for Castilla-La Mancha"

Illa, meanwhile, has described the news as "very satisfactory", and explained that it is a plant that will participate in the AstraZeneca vaccine and the University of Oxford, something that has been described as a "milestone" for Castilla- La Mancha, Spain and for all of Europe.

"I get a very positive impression," said the minister, while taking the opportunity to congratulate everyone, from health personnel to workers of all companies that make it possible and research staff to get vaccinated with safety and efficacy as soon as possible to a significant number of Spanish and European citizens.

Insud Pharma is a company with a track record of more than 40 years, dedicated to the development and research of drugs and active ingredients, which has a total of 6 plants in Spain and employs more than 6,000 people around the world.

In Spain, Insud Pharma has two plants in Azuqueca de Henares, one in Alcalá de Henares and three in León and has more than 2,200 employees.

Insud Pharma produces through its three synergistic units: industrial (Chemo), brand (Exeltis) and biotechnology (mAbxience).

600 direct jobs, 800 indirect

Chemo generates more than 600 direct and 800 indirect jobs in Azuqueca de Henares, and the facilities chosen to fill the vaccine vials are Universal Farma, a state-of-the-art plant, inaugurated in 2017, and dedicated to injectable drugs.

The president of AstraZeneca in Spain,

Rick R. Suárez

, has stated that "since the beginning of the pandemic, AstraZeneca has worked tirelessly to fight the virus, and an example of this is the development of a potential vaccine against

Covid-19

".

"The fact that part of the vaccine manufacturing process is based in our country - Suárez added - as in other countries throughout Europe, makes us feel even more proud that together we can contribute to eradicating the virus and boost the economy of the world and of Spain, one of our key markets ".

For his part, the CEO of Insud Pharma,

Lucas Sigman

, has stated: "Having been chosen partners for a project as crucial as this, both in Latin America and in Spain, shows the solvency of our group as a first-line partner" .

According to the criteria of The Trust Project

Know more

  • Coronavirus

  • Covid 19

  • Vaccinations

  • Science and Health

Exclusive images The vaccines against Covid leave the Guadalajara distribution center after spending the night at the Lerma Civil Guard headquarters

Coronavirus What you can do (and what not) after getting vaccinated

Health Illa opens the door to modify the curfew, but insists on the no to confinement

See links of interest

  • 2021 calendar

  • Spain - Tunisia, live

  • Borussia Mönchengladbach - SV Werder Bremen

  • Cadiz - Levante

  • Real Valladolid - Elche

  • 1. FSV Mainz 05 - VfL Wolfsburg